亚太传统医药2025,Vol.21Issue(1) :232-236.DOI:10.11954/ytctyy.202501046

中医药治疗慢性阻塞性肺疾病合并呼吸衰竭临床研究进展

Clinical Research Progress on Traditional Chinese Medicine Treatment of Chronic Obstructive Pulmonary Disease Combined with Respiratory Failure

徐一夫 曲妮妮
亚太传统医药2025,Vol.21Issue(1) :232-236.DOI:10.11954/ytctyy.202501046

中医药治疗慢性阻塞性肺疾病合并呼吸衰竭临床研究进展

Clinical Research Progress on Traditional Chinese Medicine Treatment of Chronic Obstructive Pulmonary Disease Combined with Respiratory Failure

徐一夫 1曲妮妮2
扫码查看

作者信息

  • 1. 辽宁中医药大学,辽宁沈阳 110847
  • 2. 辽宁中医药大学附属医院,辽宁沈阳 110032
  • 折叠

摘要

慢性阻塞性肺疾病(COPD)作为呼吸系统常见疾病之一,具有发病率高、病程长、病情易反复等特点.相关研究发现,在其疾病发展过程中,COPD合并呼吸衰竭的发生率较高,严重危害了患者生命安全.目前,现代医学在治疗该疾病时多采用抗感染、扩张支气管、吸氧等对症治疗,在一定程度上存在局限性且患者预后较差,经济负担过重.中医药治疗COPD具有安全有效、不良反应小等优势.综述近几年关于COPD合并呼吸衰竭的中医药临床研究,以期为临床治疗COPD合并呼吸衰竭及相关研究提供参考.

Abstract

As one of the common respiratory diseases,chronic obstructive pulmonary disease(COPD)has the character-istics of a high incidence rate,long course of disease,and easy recurrence.Related studies have found that the incidence of COPD combined with respiratory failure is high during the development of the disease,which seriously endangers the safety of patients.At present,Western medicine often uses conventional treatments such as anti-infection,bronchodila-tion,and oxygen therapy to treat this disease,which has certain limitations and poor patient prognosis,resulting in ex-cessive economic burden.The advantages of safe and effective treatment and minimal adverse reactions have gradually emerged with the continuous development of traditional Chinese medicine.To review the clinical research of traditional Chinese medicine on COPD combined with respiratory failure in recent years to provide ideas and references for the clinical treatment of COPD combined with respiratory failure and related research.

关键词

慢性阻塞性肺疾病/呼吸衰竭/病因/病机/中医药治疗

Key words

Chronic Obstructive Pulmonary Disease/Respiratory Failure/Etiology/Pathogenesis/Traditional Chinese Medicine Treatment

引用本文复制引用

出版年

2025
亚太传统医药
中国民族医药学会 湖北省科技信息研究院

亚太传统医药

影响因子:0.743
ISSN:1673-2197
段落导航相关论文